| Study title | A Randomized, Double-blind, Dose-ranging, Placebo-controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Primary Sclerosing Cholangitis (PSC) and Suspected Liver Fibrosis (INTEGRIS-PSC) |
| Disease or condition | Primary sclerosing cholangitis |
| Study type | Interventional (Clinical Trial) |
| Intervention/treatment | PLN-74809 or placebo |
| Phase | 3 |
| Study site | Duke University |
| Study location | Durham |
| Principal investigator name | Andrew Muir |
| Study coordinator name and email | Adele Gaskin, adele.gaskin@duke.edu |
| Phone contact | 919-684-0742 |
| Clinicaltrials.gov link | https://clinicaltrials.gov/ct2/show/NCT04480840 |